0001447362-21-000067.txt : 20210402
0001447362-21-000067.hdr.sgml : 20210402
20210402180516
ACCESSION NUMBER: 0001447362-21-000067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KABAKOFF DAVID S
CENTRAL INDEX KEY: 0001024008
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 21803240
MAIL ADDRESS:
STREET 1: C/O SPIROS DEVELOPMENT CORP II INC
STREET 2: 7475 LUSK BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wf-form4_161740106185755.xml
FORM 4
X0306
4
2021-03-31
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001024008
KABAKOFF DAVID S
C/O CASTLE BIOSCIENCES, INC.
820 S. FRIENDSWOOD DRIVE, SUITE 201
FRIENDSWOOD
TX
77546
1
0
0
0
Common Stock
2021-03-31
4
S
0
20000
67.5626
D
713577
I
By L.P.
Common Stock
2021-03-31
4
S
0
10000
68.1545
D
703577
I
By L.P.
Common Stock
2021-04-01
4
S
0
40000
70.0013
D
663577
I
By L.P.
Common Stock
2021-04-01
4
S
0
20000
70.8017
D
643577
I
By L.P.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by Sofinnova HealthQuest Partners, L.P. on December 17, 2020.
This transaction was executed in multiple trades at prices ranging from $67.0821 to $68.0430, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by Sofinnova HealthQuest Partners, L.P., or HealthQuest Partners. HealthQuest Venture Management, L.L.C., or HealthQuest Management, is the general partner of HealthQuest Partners. David Kabakoff, Ph.D., the Reporting Person, is a partner of HealthQuest Management. Garheng Kong is the managing member of HealthQuest Management and has sole voting and investment power over the shares held by HealthQuest Partners. Each of HealthQuest Management, Mr. Kong and Dr. Kabakoff disclaims beneficial ownership over all shares held by HealthQuest Partners except to the extent of any pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $69.3558 to $70.3535, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $70.5502 to $71.0532, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Greg Acosta, Attorney-in-fact
2021-04-02